Alithea Genomics: Funding, Investors & Team (Sep 2026)
The backgrounds of Alithea Genomics in bioengineering, molecular biology, genomics, and lab operations showcase their expertise that complements each other.
Alithea Genomics has raised $9.6M across 5 funding rounds on record, the most recent a Seed of $3.8M announced in Mar 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alithea Genomics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Alithea Genomics Funding Rounds
Alithea Genomics raised $1.0M in a Seed announced in May 2022.
8 months later, an undisclosed round of $1.1M was announced in Jan 2023.
2 months later, an undisclosed round of $540k was announced in Mar 2023.
1 years later, an undisclosed round of $3.2M was announced in Mar 2024.
2 years later, a Seed of $3.8M was announced in Mar 2026.
Alithea Genomics Founders and Leadership Team
Contact details for the Alithea Genomics team: 1 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Alithea Genomics Funding Compared to Other Biotechnology Startups
Alithea Genomics' latest round of $3.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alithea Genomics in Biotechnology and Lausanne
Companies Similar to Alithea Genomics
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Alithea Genomics Funding FAQs
What does Alithea Genomics do?
The backgrounds of Alithea Genomics in bioengineering, molecular biology, genomics, and lab operations showcase their expertise that complements each other.
How much funding has Alithea Genomics raised?
Alithea Genomics has raised $9.6M across 5 rounds on record. The most recent is a Seed of $3.8M announced in Mar 2026.
When did Alithea Genomics last raise funding?
Alithea Genomics' most recent funding round on record is a Seed of $3.8M, announced in Mar 2026.
Who founded Alithea Genomics?
FundedIQ lists Daniel Alpern (Founder), Frederik Decouttere Ceo At Alithea Genomics (Founder), Riccardo Dainese (Founder) at Alithea Genomics.
Where is Alithea Genomics headquartered?
Alithea Genomics is based in Lausanne, Vaud, Switzerland.
How many employees does Alithea Genomics have?
Alithea Genomics is in the 11-50 employee band.
How does Alithea Genomics' funding compare to other Biotechnology startups?
Alithea Genomics' latest round of $3.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Alithea Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alithea Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.